Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2011-6-13
pubmed:abstractText
High doses of insulin and the insulin analog AspB10 have been reported to increase mammary tumor incidence in female rats likely via receptor-mediated mechanisms, possibly involving enhanced IGF-1 receptor activation. However, insulin and IGF-1 receptor functionality and intracellular signaling in the rat mammary gland in vivo is essentially unexplored. The authors investigated the effect of a single subcutaneous dose of 600 nmol/kg human insulin or IGF-1 on Akt and ERK1/2 phosphorylation in rat liver, colon, and mammary gland. Rat tissues were examined by Western blotting and immunohistochemistry by phosphorylation-specific antibodies. Insulin as well as IGF-1 caused Akt phosphorylation in mammary epithelial cells, with myoepithelial and basal epithelial cells being most sensitive. IGF-1 caused stronger Akt phosphorylation than insulin in mammary gland epithelial cells. Phosphorylation of ERK1/2 was not influenced by insulin or IGF-1. Rather, in liver and mammary gland P-ERK1/2 appeared to correlate with estrous cycling, supporting that ERK1/2 has important physiological roles in these two organs. In short, these findings supported that the rat mammary gland epithelium expresses functional insulin and IGF-1 receptors and that phosphorylation of Akt as well as ERK1/2 may be of value in understanding the effects of exogenous insulin in the rat mammary gland and colon.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1533-1601
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
623-40
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:21558470-Animals, pubmed-meshheading:21558470-Blotting, Western, pubmed-meshheading:21558470-Breast, pubmed-meshheading:21558470-Colon, pubmed-meshheading:21558470-Epithelial Cells, pubmed-meshheading:21558470-Female, pubmed-meshheading:21558470-Humans, pubmed-meshheading:21558470-Immunohistochemistry, pubmed-meshheading:21558470-Insulin, pubmed-meshheading:21558470-Insulin-Like Growth Factor I, pubmed-meshheading:21558470-Liver, pubmed-meshheading:21558470-Mammary Glands, Animal, pubmed-meshheading:21558470-Mitogen-Activated Protein Kinase 1, pubmed-meshheading:21558470-Mitogen-Activated Protein Kinase 3, pubmed-meshheading:21558470-Phosphorylation, pubmed-meshheading:21558470-Proto-Oncogene Proteins c-akt, pubmed-meshheading:21558470-Rats, pubmed-meshheading:21558470-Rats, Sprague-Dawley, pubmed-meshheading:21558470-Receptor, IGF Type 1, pubmed-meshheading:21558470-Signal Transduction
pubmed:year
2011
pubmed:articleTitle
In situ phosphorylation of Akt and ERK1/2 in rat mammary gland, colon, and liver following treatment with human insulin and IGF-1.
pubmed:affiliation
Department of Veterinary Disease Biology, Faculty of Life Sciences, University of Copenhagen, Denmark. hhvd@novonordisk.com
pubmed:publicationType
Journal Article, Comparative Study